AR and diabetic neuropathy: In diabetic neuropathy, evidence from knockout mice or pharmacological inhibitors indicates that activation of AR, which converts glucose to sorbitol in a process that causes oxidative stress, is necessary for subsequent axonal loss.9 We postulated that SCI might also activate AR, causing axonal degeneration and loss, given that the enzyme can be activated by ischemia attributable to injury.5,6